Literature DB >> 15490413

Oxidative stress in uremia: nature, mechanisms, and potential consequences.

Nosratola D Vaziri1.   

Abstract

Oxidative stress has emerged as a constant feature of chronic renal failure (CRF). The presence of oxidative stress in CRF is evidenced by an overabundance of lipid, carbohydrate, and protein oxidation products in the plasma and tissues of uremic patients and animals. We recently have shown that oxidative stress in CRF animals is associated with and, in part, owing to up-regulation of superoxide-producing enzyme, nicotinamide-adenine dinucleotide phosphate (NAD(P)H) oxidase, and down-regulation of superoxide dismutase (SOD). The functional significance of these findings was confirmed by favorable response to administration of the cell-permeable SOD-mimetic agent, tempol, in CRF rats. Oxidative stress in CRF plays an important role in the pathogenesis of the associated hypertension (oxidation of NO and arachidonic acid and vascular remodeling), cardiovascular disease (oxidation of lipoproteins, atherogenesis), neurologic disorders (nitration of brain proteins, oxidation of myelin), anemia (reduction of erythrocyte lifespan), inflammation (nuclear factor kappa B activation), fibrosis, apoptosis, and accelerated aging. The CRF-induced oxidative stress is aggravated by diabetes, uncontrolled hypertension, and autoimmune diseases, which independently increase production of reactive oxygen intermediates, and frequently are associated with CRF. In addition, dialysis treatment (blood interaction with dialyzer membrane and dialysate impurities), acute and chronic infections (blood access infection, hepatitis, and so forth), and excessive parenteral iron administration intensify CRF-associated oxidative stress and its adverse consequences in patients with end-stage renal disease. The problem is compounded by limited intake of fresh fruits and vegetables (K(+) restriction), which contain numerous natural phytochemicals and antioxidant vitamins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15490413     DOI: 10.1016/j.semnephrol.2004.06.026

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  116 in total

1.  Role of Nrf2 dysfunction in uremia-associated intestinal inflammation and epithelial barrier disruption.

Authors:  Wei Ling Lau; Shu-Man Liu; Sogol Pahlevan; Jun Yuan; Mahyar Khazaeli; Zhenmin Ni; Jefferson Y Chan; Nosratola D Vaziri
Journal:  Dig Dis Sci       Date:  2014-11-16       Impact factor: 3.199

2.  Salutary effects of hemodialysis on low-density lipoprotein proinflammatory and high-density lipoprotein anti-inflammatory properties in patient with end-stage renal disease.

Authors:  Nosratola D Vaziri; Kaveh Navab; Pavan Gollapudi; Hamid Moradi; Madeleine V Pahl; Cyril H Barton; Alan M Fogelman; Mohamad Navab
Journal:  J Natl Med Assoc       Date:  2011-06       Impact factor: 1.798

3.  LCZ696 (Sacubitril/valsartan) ameliorates oxidative stress, inflammation, fibrosis and improves renal function beyond angiotensin receptor blockade in CKD.

Authors:  Wanghui Jing; Nosratola D Vaziri; Ane Nunes; Yasunori Suematsu; Ted Farzaneh; Mahyar Khazaeli; Hamid Moradi
Journal:  Am J Transl Res       Date:  2017-12-15       Impact factor: 4.060

4.  A Pharmacologic "Stress Test" for Assessing Select Antioxidant Defenses in Patients with CKD.

Authors:  Richard A Zager; Ali C M Johnson; Alvaro Guillem; Jeff Keyser; Bhupinder Singh
Journal:  Clin J Am Soc Nephrol       Date:  2020-04-14       Impact factor: 8.237

5.  Oxidative DNA damage and mortality in hemodialysis and peritoneal dialysis patients.

Authors:  Hong Xu; Makoto Watanabe; Abdul Rashid Qureshi; Olof Heimbürger; Peter Bárány; Björn Anderstam; Monica Eriksson; Peter Stenvinkel; Bengt Lindholm
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

6.  Increased Levels of Modified Advanced Oxidation Protein Products Are Associated with Central and Peripheral Blood Pressure in Peritoneal Dialysis Patients.

Authors:  Hong Xu; Ivan Cabezas-Rodriguez; Abdul Rashid Qureshi; Olof Heimburger; Peter Barany; Sunna Snaedal; Björn Anderstam; Ann-Christin Bragfors Helin; Juan Jesus Carrero; Peter Stenvinkel; Bengt Lindholm
Journal:  Perit Dial Int       Date:  2014-03-01       Impact factor: 1.756

7.  Plasma phospholipid transfer protein, cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase in end-stage renal disease (ESRD).

Authors:  Madeleine V Pahl; Zhenmin Ni; Lili Sepassi; Hamid Moradi; Nosratola D Vaziri
Journal:  Nephrol Dial Transplant       Date:  2009-03-18       Impact factor: 5.992

Review 8.  Causes of dysregulation of lipid metabolism in chronic renal failure.

Authors:  Nosratola D Vaziri
Journal:  Semin Dial       Date:  2009 Nov-Dec       Impact factor: 3.455

9.  High-calorie diet partially ameliorates dysregulation of intrarenal lipid metabolism in remnant kidney.

Authors:  Hyun Ju Kim; Jun Yuan; Keith Norris; Nosratola D Vaziri
Journal:  J Nutr Biochem       Date:  2009-12-01       Impact factor: 6.048

10.  Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure.

Authors:  Maria D'Apolito; Xueliang Du; Haihong Zong; Alessandra Catucci; Luigi Maiuri; Tiziana Trivisano; Massimo Pettoello-Mantovani; Angelo Campanozzi; Valeria Raia; Jeffrey E Pessin; Michael Brownlee; Ida Giardino
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.